Page last updated: 2024-08-16

ag 1879 and dasatinib

ag 1879 has been researched along with dasatinib in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (11.11)29.6817
2010's13 (72.22)24.3611
2020's3 (16.67)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Jadhav, A; Kerns, E; Nguyen, K; Shah, P; Sun, H; Xu, X; Yan, Z; Yu, KR1
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR1
Kabir, M; Kerns, E; Neyra, J; Nguyen, K; Nguyễn, ÐT; Shah, P; Siramshetty, VB; Southall, N; Williams, J; Xu, X; Yu, KR1
Ingley, E; Klinken, SP; Lucet, IS; Rossjohn, J; Williams, NK1
Badu-Nkansah, K; Hynes, RO; Liu, H; Ong, SE; Schindler, J; White, FM1
Bareford, MD; Cruickshanks, N; Dai, Y; Dent, P; Grant, S; Hamed, HA; Hubbard, N; Mitchell, C; Tang, Y; Tye, G; Yacoub, A1
Ahmed, N; Burke, J; Chang, CY; Gao, M; Muckelbauer, J; Sack, JS; Tebben, AJ; Tino, J; Xie, D1
Congleton, J; MacDonald, R; Yen, A1
Calcabrini, A; Gómez-Domínguez, D; Gómez-López, G; Martín-Forero, E; Martín-Pérez, J; Molinari, A; Morte, B; Sánchez-Bailón, MP; Wagner, KU1
Chen, Y; Clayman, GL; Frederick, MJ; Gallick, GE; Henderson, YC; Lai, SY; Ryu, J; Toro-Serra, R; Zhou, G1
Congleton, J; MacDonald, R; Malavasi, F; Shen, M; Yen, A1
Balart, J; Baro, M; de Llobet, LI; Figueras, A; Mesia, R; Skvortsova, I1
Annis, MG; Hsu, BE; Park, M; Savage, P; Siegel, PM; Tabariès, S; Tam, CE1
Camerino, GM; Capogrosso, RF; Cappellari, O; Conte, E; Cozzoli, A; Cutrignelli, A; De Bellis, M; De Luca, A; Denora, N; Giustino, A; Mantuano, P; Rolland, JF; Sanarica, F1
Contreras, P; Díaz, J; Díaz-Valdivia, N; Guerrero, S; Leyton, L; Lobos-González, L; Martínez, S; Ortiz, R; Quest, AFG; Simón, L1
Li, W; Li, Z; Liu, N; Sun, X; Tan, G; Xie, F; Xie, X1

Other Studies

18 other study(ies) available for ag 1879 and dasatinib

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
Highly predictive and interpretable models for PAMPA permeability.
    Bioorganic & medicinal chemistry, 2017, 02-01, Volume: 25, Issue:3

    Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Humans; Models, Biological; Organic Chemicals; Regression Analysis; Support Vector Machine

2017
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
    Bioorganic & medicinal chemistry, 2019, 07-15, Volume: 27, Issue:14

    Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility

2019
Retrospective assessment of rat liver microsomal stability at NCATS: data and QSAR models.
    Scientific reports, 2020, 11-26, Volume: 10, Issue:1

    Topics: Animals; Computer Simulation; Databases, Factual; Drug Discovery; High-Throughput Screening Assays; Liver; Machine Learning; Male; Microsomes, Liver; National Center for Advancing Translational Sciences (U.S.); Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Rats; Rats, Sprague-Dawley; Retrospective Studies; United States

2020
Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state.
    The Journal of biological chemistry, 2009, Jan-02, Volume: 284, Issue:1

    Topics: Adenylyl Imidodiphosphate; Animals; Apoenzymes; B-Lymphocytes; Catalytic Domain; Crystallography, X-Ray; Dasatinib; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mice; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyrimidines; src-Family Kinases; Thiazoles

2009
CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Jan-25, Volume: 108, Issue:4

    Topics: Animals; Antigens, CD; Antigens, Neoplasm; Blotting, Western; Cell Adhesion; Cell Adhesion Molecules; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Dasatinib; Enzyme Activation; Fluorescent Antibody Technique; HEK293 Cells; Humans; Lung Neoplasms; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Neoplasm Proteins; Pyrimidines; src-Family Kinases; Tandem Mass Spectrometry; Thiazoles; Transplantation, Heterologous

2011
Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death.
    Cancer biology & therapy, 2011, Aug-01, Volume: 12, Issue:3

    Topics: Animals; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; bcl-X Protein; Benzimidazoles; Benzodioxoles; Breast Neoplasms; Cell Death; Cell Line, Transformed; Cell Transformation, Neoplastic; Checkpoint Kinase 1; Dasatinib; Female; Fibroblasts; Humans; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Protease Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-yes; Pyrimidines; Quinazolines; Radiation Tolerance; src-Family Kinases; Thiazoles

2011
X-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinase.
    Chemical biology & drug design, 2011, Volume: 78, Issue:5

    Topics: Agammaglobulinaemia Tyrosine Kinase; Binding Sites; Chromosomes, Human, X; Crystallography, X-Ray; Dasatinib; Humans; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Pyrimidines; src-Family Kinases; Thiazoles

2011
Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells.
    Leukemia, 2012, Volume: 26, Issue:6

    Topics: Antineoplastic Agents; Blotting, Western; Cell Cycle; Cell Differentiation; Dasatinib; Extracellular Signal-Regulated MAP Kinases; Flow Cytometry; Humans; Immunoprecipitation; Leukemia, Myeloid; Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Proto-Oncogene Proteins c-raf; Pyrimidines; RNA, Small Interfering; Signal Transduction; src-Family Kinases; Thiazoles; Tretinoin; Tumor Cells, Cultured

2012
Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells.
    Cellular signalling, 2012, Volume: 24, Issue:6

    Topics: Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Dasatinib; Female; Humans; Indoles; Neoplasm Invasiveness; Paxillin; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Sulfonamides; Thiazoles

2012
Src inhibitors in suppression of papillary thyroid carcinoma growth.
    Head & neck, 2014, Volume: 36, Issue:3

    Topics: Animals; Carcinoma; Carcinoma, Papillary; Cell Proliferation; Dasatinib; Disease Models, Animal; Indoles; Mice; Mice, Inbred Strains; Mitogen-Activated Protein Kinase 1; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; Signal Transduction; src-Family Kinases; Sulfonamides; Thiazoles; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tumor Cells, Cultured

2014
Phosphorylation of c-Cbl and p85 PI3K driven by all-trans retinoic acid and CD38 depends on Lyn kinase activity.
    Cellular signalling, 2014, Volume: 26, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; ADP-ribosyl Cyclase 1; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Class Ia Phosphatidylinositol 3-Kinase; Dasatinib; HL-60 Cells; Humans; Leukemia, Myeloid; Membrane Glycoproteins; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-cbl; Proto-Oncogene Proteins c-vav; Pyrimidines; src-Family Kinases; Thiazoles; Tretinoin

2014
Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours.
    British journal of cancer, 2014, Sep-23, Volume: 111, Issue:7

    Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Proliferation; Cetuximab; Dasatinib; DNA Replication; Dose Fractionation, Radiation; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Pyrimidines; ras Proteins; src-Family Kinases; Thiazoles; Tumor Burden; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2014
Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
    Oncotarget, 2015, Apr-20, Volume: 6, Issue:11

    Topics: Animals; Apoptosis; Carcinoma; Cell Line, Tumor; Claudins; Dasatinib; Female; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplasm Proteins; Promoter Regions, Genetic; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-fos; Pyrimidines; RNA Interference; RNA, Messenger; RNA, Neoplasm; Signal Transduction; src-Family Kinases; Transcription Factor AP-1; Transcription, Genetic; Triple Negative Breast Neoplasms

2015
Proof-of-concept validation of the mechanism of action of Src tyrosine kinase inhibitors in dystrophic mdx mouse muscle: in vivo and in vitro studies.
    Pharmacological research, 2019, Volume: 145

    Topics: Animals; Cell Line; Cell Survival; Dasatinib; Dystroglycans; Liver; Male; Mice, Inbred mdx; Muscle Fatigue; Muscle Strength; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Protein Kinase Inhibitors; Pyrimidines; Reproducibility of Results; src-Family Kinases; Torque

2019
Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells.
    Biochemical pharmacology, 2020, Volume: 177

    Topics: Animals; Caveolin 1; Cell Line, Tumor; Cell Movement; Cell Survival; Dasatinib; Female; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neuropeptides; Phosphorylation; Protein Kinase Inhibitors; Pyrimidines; rac1 GTP-Binding Protein; Skin Neoplasms; src-Family Kinases; Transfection; Tyrosine

2020
Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo.
    Biological & pharmaceutical bulletin, 2021, Volume: 44, Issue:9

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Dasatinib; Disulfiram; Drug Synergism; Humans; Male; Mice; Pancreatic Neoplasms; Protein Kinase Inhibitors; Pyrimidines; src-Family Kinases; Xenograft Model Antitumor Assays

2021